Already registered? Need to register? Register
PCSK9 Forum

rss LinkedIn News
rss LinkedIn Latest News Updates
Lp(a) Satellite Meeting

FREE eBOOK

PCSK9 Inhibition

Introductory Guide

New therapies in cardiovascular risk reductionPCSK9 Inhibition Introductory GuideView the eBook

About the PCSK9 Education and Research Forum

PCSK9 Education and Research Forum is the independent resource on PCSK9 science and its translation into critically important new treatments to lower low density lipoprotein cholesterol (LDL-C), which promise to transform the prognosis of millions of patients with hypercholesterolaemia (cholesterol disorders), accelerated atherosclerotic vascular heart disease and a high risk of premature cardiovascular (CV) death and disability.
Aims & ObjectivesMission StatementEditorial BoardPartnership & OutreachForthcoming Meetings
Why are new treatments needed?

Why are new
treatments needed?

Read more »
What are the benefits of PCSK9 inhibitors?

What are the benefits
of PCSK9 inhibitors?

Read more »
PCSK9 inhibitors in real world practice?

PCSK9 inhibitors in
real world practice?

Read more »
Most viewed

2016 ACC Scientific Sessions News

GAUSS-3 highlights issues with diagnosis of statin intolerance
PCSK9 Forum Co-Editor Professor Henry Ginsberg discusses the findings.


ACC updates guidance on non-statin LDL lowering therapies
In a prelude to this year’s Annual Congress, the American College of Cardiology has released a new consensus document.

From the Editors

PCSK9 therapy- the solution to all cardiovascular disease?PCSK9 therapy- the solution to all cardiovascular disease?Anthony Wierzbicki

Prof. Anthony S. Wierzbicki, Guy’s & St Thomas’ Hospitals, London, UK discusses evidence from a number of meta-analyses of PCSK9 inhibitor treatment.


Read the full article